Detalles de la búsqueda
1.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314897
2.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870594
3.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Ann Hematol
; 100(9): 2279-2292, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523289
4.
Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance.
Leuk Lymphoma
; 63(4): 799-812, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35188040
5.
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system.
Leuk Lymphoma
; 60(7): 1721-1730, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30424699
6.
PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?
Hemasphere
; 7(11): e965, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38027423
Resultados
1 -
6
de 6
1
Próxima >
>>